PROK (ProKidney Corp.) Total Enterprise Value

ProKidney Pharma - graphic logo of issuer PROK

ProKidney Corp. (PROK) relies on a virtual business model, outsourcing drug manufacturing and clinical trials to third-party contractors. The company is developing an innovative cell therapy for kidney regeneration to eliminate the need for dialysis. This Enterprise Value chart on GURU.Markets stands at 1386.35, with the upcoming results of the REACT Phase 3 trials serving as the primary growth driver.

PROK (prokidney.com) Total Company Value history from 11/23/2025 to 10/28/2026

ProKidney Corp. (PROK) - metric breakdowns and financial figures

- price and consensus price forecast:
Price Performance Chart ProKidney Corp|PROK - Price Target Chart
- market capitalization data:
Market Value ProKidney|PROK - Total Company Value
- book capitalization data:
Book Value per Share ProKidney|PROK - Company Book Value|Market Capitalization to Net Assets prokidney.com|PROK - Company Total Assets
- debt and liquidity data:
All Debt to Shareholders' Equity Ratio ProKidney Corp.|PROK - Long-Term Debt to Capital|Short-Term Debt to Capital prokidney.com|PROK - Company Debts|Debt to Net Assets Ratio ProKidney|PROK - Company Long-Term Debt|Company Current Liabilities ProKidney
Comprehensive company analysis:ProKidney Corp (PROK)
Original product of ProKidney Corp.

For the high-risk biotech startup ProKidney Corp. (PROK), enterprise value serves as the key metric for investment attractiveness. This metric aggregates market capitalization and debt obligations, minus existing cash and cash equivalents. By analyzing the calculated enterprise value, an investor can determine the actual cost of a full asset buyout. The trend in calculated enterprise value reflects the financing efficiency of R&D and cellular development. This indicator allows for an assessment of the real scale of capital raised to combat diabetes.

Competitor analysis for ProKidney Corp.

Travere Therapeutics Inc - Value Adjusted for Debt and Cash|ARDX (Ardelyx Pharma) - Total Company Value|AKBA: Total Enterprise Value|TVRD: Total Company Value|DMAC (diamedica.com) - Enterprise Value|Total Company Value Unicycive Therapeutics, Inc. UNCY|Full Business Value rockwellmed.com|Cadrenal Therapeutics, Inc (CVKD) - Enterprise Value|Value Adjusted for Debt and Cash Conduit Therapeutics (CDT)|Enterprise Value CALT (Calliditas Therapeutics AB)|Renalytix, plc - Enterprise Value|Total Company Value ZyVersa (ZVSA)